Status:
COMPLETED
Can Electroencephalography (EEG) Identify the Different Dimensions of Pain in Fibromyalgia?
Lead Sponsor:
Universidade Federal de Pernambuco
Conditions:
Fibromyalgia
Eligibility:
FEMALE
18-60 years
Brief Summary
Studies with quantitative electroencephalogram (qEEG) in people with fibromyalgia showed the existence of distinct patterns of brain electrical activity when compared to healthy individuals. Such dysf...
Detailed Description
The study was a pilot study with a cross-sectional and exploratory design carried out from 2020 to 2022. A quantitative electroencephalographic analysis was performed with women with Fibromyalgia and ...
Eligibility Criteria
Inclusion
- widespread pain index (WPI) ≥ 7;
- symptom severity scale (SS) = 5;
- WPI between 4-6 and (iv) SS ≥ 9;
- generalized pain, as defined as pain in at least 4 regions of the body;
- having been diagnosed with fibromyalgia at least three months ago.
Exclusion
- autoimmune or inflammatory diseases that cause pain, such as rheumatoid arthritis, systemic lupus erythematosus, or inflammatory bowel disease;
- history of neurological or psychotic disorders;
- cognitive impairment that prevents the conduct of study procedures;
- patients with a history of abusive use of alcohol or other illicit drugs;
- patients who have any contraindication for the use of the qEEG (excessive seborrhoea, scalp infection or pediculosis).
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT05962658
Start Date
April 1 2021
End Date
December 31 2022
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Applied Neuroscience Laboratory
Recife, Pernambuco, Brazil, 50740-560